XML 81 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating activities      
Net loss $ (20,729,000) $ (29,964,000) $ (28,526,000)
Reconciliation of net loss to net cash used in operating activities:      
Depreciation 115,000 148,000 123,000
Amortization of premium/discount on available-for-sale securities (51,000) (2,000) 131,000
Unrealized loss on forward foreign currency contracts included in net income (127,000)
Foreign currency remeasurement (loss)/gain (25,000) (173,000) 76,000
Stock-based compensation 3,429,000 3,227,000 3,343,000
Changes in:      
Prepaid expenses and other assets 141,000 297,000 246,000
Interest receivable 49,000 (46,000) (26,000)
Accounts payable and accrued expenses (6,162,000) 4,161,000 1,073,000
Net cash used in operating activities (23,233,000) (22,352,000) (23,687,000)
Investing activities      
Purchases of available-for-sale investments (15,443,000) (32,942,000) (39,756,000)
Proceeds from maturities of available-for-sale investments 31,990,000 16,878,000 59,943,000
Proceeds from sale of available-for-sale investments 1,999,000
Purchase of property and equipment (119,000) (35,000) (271,000)
Net cash provided by investing activities 18,427,000 (16,099,000) 19,916,000
Financing activities      
Proceeds from issuance of common stock, net of issuance costs 2,853,000 1,288,000
Proceeds from the issuance of Series A Convertible Preferred Stock, net of issuance costs 21,523,000
Proceeds from issuance of common stock under ESPP 132,000 130,000 11,000
Exercise of stock options 108,000 197,000
Net cash provided by financing activities 2,985,000 23,049,000 208,000
Effect of exchange rate changes on cash 22,000 180,000 (76,000)
Decrease in cash, cash equivalents and restricted cash (1,799,000) (15,222,000) (3,639,000)
Cash, cash equivalents and restricted cash, beginning of period 21,192,000 36,414,000 40,045,000
Cash, cash equivalents and restricted cash, end of period 19,393,000 21,192,000 36,414,000
Supplemental disclosure of non-cash investing and financing activities      
Accretion of convertible preferred stock $ 6,747,000